Gilead Sciences logo
Home
Facebook
Twitter
Linkedin
Summary:
COMPANY:​
Gilead Sciences
INDUSTRIES:​
Biopharma, Biotechnology, Commercial, Health Care, Manufacturing, Pharmaceutical
HEADQUARTERS:​
Foster City, California, United States
ABOUT:
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
STOCK SYMBOL:
GILD: BIT – Italian Stock Exchange
IPO STATUS:
Public
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead’s primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions. Gilead Sciences was founded in 1987 and headquartered in Foster City, California.
POWERED BY CRUNCHBASE
Financials:
FUNDING (USD):​
STATUS:
For Profit
INVESTORS:​
TOP 5 INVESTORS:​
FOUNDERS:​
Michael L. Riordan
LAST LEADERSHIP HIRE:
EMPLOYEES:
10001+
ACQUISITIONS​:

YouTube

Gilead Sciences

The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet. For more than 30 years, we’ve pursued it, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.

Read more: http://bit.ly/2vbkoI7

Gilead Sciences
As conversations about racial equity began across the United States and around the world last summer following the killing of George Floyd, Gilead’s Leadership Team started a dialogue with the company’s Black employees. In the third episode of our "Possible" documentary series, meet Valerie Brown, Senior Vice President of Quality Assurance, who discusses that dialogue and shares her optimism for the future. Read more: http://bit.ly/3uxhk2V Watch Episode 2: https://bit.ly/3aTNJZB
Episode 3: Championing Possible
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_pR-mpao_wEE
Morris Singletary is founder of PoZitive2PoSitive, a nonprofit organization that works to get important educational messaging around HIV to communities of color. Here, he discusses growing up in the Southern United States and explains his belief that working with the Black church is essential in addressing the HIV epidemic.
Power Within Reach | How Faith Can Help Fight HIV Stigma in the South
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_MKrfGPqVDOA
Through our 10-year COMPASS Initiative, we’ve been focused on reaching communities in the Southern United States most impacted by the HIV epidemic. Now, we’re joining forces with the Wake Forest University School of Divinity and expanding the initiative to faith-based communities.
Power Within Reach | Working to End the HIV Epidemic with Wake Forest
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_L7qTl5oEpp4
“What are You Waiting For,” by Gianfranco Antacido, is a video from the CcomeCurabile awareness Campaign. The campaign was created to raise awareness about hepatitis C in an innovative and engaging way. The contest is part of C Come Curabile, an HCV awareness campaign promoted by Gilead in collaboration with AISF (Italian Association of Liver Diseases, EpaC Onlus (National Federation of Associations of Volunteering for Liver Diseases and Liver Transplantation), The Bridge Foundation and SIMIT, Italian Society of Infectious and Tropical Diseases.
What are You Waiting For?
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_hCrqJyRH73k
“We Look the Same,” by Davide Murillis, is a video from the CcomeCurabile awareness Campaign. The campaign was created to raise awareness about hepatitis C in an innovative and engaging way. The contest is part of C Come Curabile, an HCV awareness campaign promoted by Gilead in collaboration with AISF (Italian Association of Liver Diseases, EpaC Onlus (National Federation of Associations of Volunteering for Liver Diseases and Liver Transplantation), The Bridge Foundation and SIMIT, Italian Society of Infectious and Tropical Diseases.
We Look the Same
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_5loJcFz2W8k
Load More... Subscribe

Twitter:

Gilead Sciences
Gilead Sciences

As Gilead focuses on racial equity within its walls and beyond, Valerie Brown, Senior Vice President of Quality Ass… https://t.co/03orfUm38m

Gilead Sciences
Gilead Sciences

We’re proud to support @glaad in furthering the conversation around #HIV and the importance of working with faith c… https://t.co/ajREdPLjQa

Gilead Sciences
Gilead Sciences

We join our partners and friends with @HRC in proudly calling for the passage of the #EqualityAct. When we combat

Gilead Sciences
Gilead Sciences

Morris Singletary, founder of PoZitive2PoSitive, grew up in the Southern United States and believes that collaborat… https://t.co/FUQhWvvg9l

Gilead Sciences
Gilead Sciences

RT @WakeDiv: We're excited to announce that Wake Divinity is the newest coordinating center to join the Gilead COMPASS Initiative.

Gilead Sciences
Gilead Sciences

Our COMPASS Initiative is focused on helping communities most affected by #HIV. Now, we’re bringing a faith-based c… https://t.co/uyYTKIDAzV

Tokyo Office:

Gran Tokyo South Tower, 16th Floor
1-9-2 Marunouchi, Chiyoda-ku
Tokyo, 100-6616

Tagged